Sanjay Gandhi to Neuroprotective Agents
This is a "connection" page, showing publications Sanjay Gandhi has written about Neuroprotective Agents.
Connection Strength
0.043
-
McGarry A, Auinger P, Kieburtz K, Geva M, Mehra M, Abler V, Grachev ID, Gordon MF, Savola JM, Gandhi S, Papapetropoulos S, Hayden M. Additional Safety and Exploratory Efficacy Data at 48 and 60 Months from Open-HART, an Open-Label Extension Study of Pridopidine in Huntington Disease. J Huntingtons Dis. 2020; 9(2):173-184.
Score: 0.043